Revolutionising Cancer Treatment with AI & Nanotechnology
At Prosemble, we are transforming cancer care with cutting-edge nanoparticle and AI technologies enhancing treatment efficacy while minimising side effects.
Cancer Cases every year
Chemotherapy Patients
Oncology market size in 2030
Pioneering Advancements
Our protein-based nanoparticle delivery system permits disease-specific targeting mechanisms, versatile drug loading for therapeutics, and atomic-level structural precision, offering enhanced engineering for superior cancer treatment.
Side effects experienced by patients...
%
Fatigue
%
Peripheral Neuropathy
%
Hair Loss
%
Liver Damage
%
Mucositis
%
Kidney Damage
%
of patients going through chemo experience significant side effects
%
fewer drugs required with Prosemble technology
%
of medicine currently gets to the tumours
Through Our Science We Are Transforming Cancer Treatment for Chemotherapy Patients
Latest News
Prosemble is pleased to announce the commencement of the immunogenicity phase of its mouse trials
Prosemble is pleased to announce the commencement of the immunogenicity phase of its mouse trials, conducted in partnership with TransCure BioServices, following the successful completion of the safety stage. This new phase will assess immune responses in CD34+...
Iryna Peretiazhko currently completing her PhD
We are proud to announce that Iryna Peretiazhko, currently completing her PhD at the Francis Crick Institute and Imperial College London under the supervision of Prof. Peter Rosenthal (Crick) and Dr Beeby (Imperial College), has had her article published in Nature —...
MedX@Düsseldorf Winners 2025
Prosemble recently participated in a competition run by the Düsseldorf regional government and is proud to share that we’ve been selected as a MedX@Düsseldorf Winners 2025—securing a booth at MEDICA 2025 in the coveted Start-up Park. MEDICA is one of the world’s...